View ValuationThis company has been acquiredThe company may no longer be operating, as it has been acquired. Find out why through their latest events.See Latest EventsOcean Bio-Chem 将来の成長Future 基準チェック /06主要情報n/a収益成長率n/aEPS成長率Household Products 収益成長4.8%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesReported Earnings • Aug 05Second quarter 2022 earnings released: US$0.03 loss per share (vs US$0.27 profit in 2Q 2021)Second quarter 2022 results: US$0.03 loss per share (down from US$0.27 profit in 2Q 2021). Revenue: US$15.2m (down 3.1% from 2Q 2021). Net loss: US$321.4k (down 112% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.分析記事 • Jun 23Here's Why Ocean Bio-Chem (NASDAQ:OBCI) Can Manage Its Debt ResponsiblyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Valuation Update With 7 Day Price Move • Jun 22Investor sentiment improved over the past weekAfter last week's 101% share price gain to US$12.86, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 20x in the Household Products industry in the US. Total returns to shareholders of 298% over the past three years.Reported Earnings • May 16First quarter 2022 earnings released: EPS: US$0.14 (vs US$0.20 in 1Q 2021)First quarter 2022 results: EPS: US$0.14 (down from US$0.20 in 1Q 2021). Revenue: US$12.7m (down 3.0% from 1Q 2021). Net income: US$1.30m (down 32% from 1Q 2021). Profit margin: 10% (down from 14% in 1Q 2021). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 7 highly experienced directors. 3 independent directors (5 non-independent directors). Independent Director Kim Krause was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.分析記事 • Apr 07Capital Investments At Ocean Bio-Chem (NASDAQ:OBCI) Point To A Promising FutureIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...Reported Earnings • Apr 01Full year 2021 earnings released: EPS: US$0.89 (vs US$1.02 in FY 2020)Full year 2021 results: EPS: US$0.89 (down from US$1.02 in FY 2020). Revenue: US$64.3m (up 16% from FY 2020). Net income: US$8.40m (down 13% from FY 2020). Profit margin: 13% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.分析記事 • Dec 16Ocean Bio-Chem (NASDAQ:OBCI) Might Become A Compounding MachineIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...分析記事 • Nov 26Ocean Bio-Chem's (NASDAQ:OBCI) Dividend Will Be US$0.03Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) will pay a dividend of US$0.03 on the 21st of December. This means the annual...分析記事 • Nov 22Ocean Bio-Chem's (NASDAQ:OBCI) Shareholders Have More To Worry About Than Only Soft EarningsA lackluster earnings announcement from Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) last week didn't sink the stock price. We...Valuation Update With 7 Day Price Move • Nov 22Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to US$9.50, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 24x in the Household Products industry in the US. Total returns to shareholders of 182% over the past three years.Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS US$0.34 (vs US$0.49 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: US$21.5m (up 12% from 3Q 2020). Net income: US$3.27m (down 30% from 3Q 2020). Profit margin: 15% (down from 24% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.分析記事 • Nov 03These 4 Measures Indicate That Ocean Bio-Chem (NASDAQ:OBCI) Is Using Debt SafelySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...分析記事 • Sep 02Ocean Bio-Chem (NASDAQ:OBCI) Will Pay A Dividend Of US$0.03Ocean Bio-Chem, Inc.'s ( NASDAQ:OBCI ) investors are due to receive a payment of US$0.03 per share on 23rd of...Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS US$0.27 (vs US$0.36 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: US$31.4m (up 100% from 2Q 2020). Net income: US$6.69m (up 94% from 2Q 2020). Profit margin: 21% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.分析記事 • Aug 17With EPS Growth And More, Ocean Bio-Chem (NASDAQ:OBCI) Is InterestingLike a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...Valuation Update With 7 Day Price Move • Aug 16Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to US$8.99, the stock trades at a trailing P/E ratio of 7.8x. Average trailing P/E is 21x in the Household Products industry in the US. Total returns to shareholders of 138% over the past three years.Seeking Alpha • Aug 05Ocean Bio-Chem And Its Real ValueOver a year and a half, OBCI shares have increased by 212.3%. OBCI had an impressive EBIT growth of 220% over the last year. Its operating margin is 22.90%, ranking better than 91% of the companies in Conglomerates industry. This article tells what investors could likely make in the future with OBCI and what the real value is versus the current share price.分析記事 • Jul 27Is Ocean Bio-Chem (NASDAQ:OBCI) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Valuation Update With 7 Day Price Move • Jul 26Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$13.00, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 17x in the Household Products industry in the US. Total returns to shareholders of 261% over the past three years.Valuation Update With 7 Day Price Move • Jun 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$12.83, the stock trades at a trailing P/E ratio of 11.2x. Average trailing P/E is 18x in the Household Products industry in the US. Total returns to shareholders of 269% over the past three years.分析記事 • May 29Estimating The Intrinsic Value Of Ocean Bio-Chem, Inc. (NASDAQ:OBCI)Does the May share price for Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) reflect what it's really worth? Today, we will...分析記事 • May 17Investors Should Be Encouraged By Ocean Bio-Chem's (NASDAQ:OBCI) Returns On CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Reported Earnings • May 16First quarter 2021 earnings released: EPS US$0.20 (vs US$0.066 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$13.1m (up 68% from 1Q 2020). Net income: US$1.90m (up 204% from 1Q 2020). Profit margin: 14% (up from 8.0% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year whereas the company’s share price has increased by 50% per year.Valuation Update With 7 Day Price Move • Apr 20Investor sentiment improved over the past weekAfter last week's 19% share price gain to US$14.17, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 20x in the Household Products industry in the US. Total returns to shareholders of 308% over the past three years.Reported Earnings • Apr 03Full year 2020 earnings released: EPS US$1.02 (vs US$0.37 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: US$55.6m (up 32% from FY 2019). Net income: US$9.62m (up 175% from FY 2019). Profit margin: 17% (up from 8.3% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 46% per year whereas the company’s share price has increased by 49% per year.分析記事 • Mar 17Ocean Bio-Chem (NASDAQ:OBCI) Seems To Use Debt Rather SparinglyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Valuation Update With 7 Day Price Move • Mar 13Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$12.50, the stock is trading at a trailing P/E ratio of 12.6x, up from the previous P/E ratio of 10.9x. This compares to an average P/E of 21x in the Household Products industry in the US. Total returns to shareholders over the past three years are 239%.分析記事 • Mar 05Be Sure To Check Out Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Before It Goes Ex-DividendOcean Bio-Chem, Inc. ( NASDAQ:OBCI ) is about to trade ex-dividend in the next four days. If you purchase the stock on...分析記事 • Feb 22Why Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Is A Dividend RockstarDividend paying stocks like Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) tend to be popular with investors, and for good reason...Valuation Update With 7 Day Price Move • Feb 18Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to US$10.32, the stock is trading at a trailing P/E ratio of 10.4x, down from the previous P/E ratio of 13x. This compares to an average P/E of 19x in the Household Products industry in the US. Total returns to shareholders over the past three years are 177%.Is New 90 Day High Low • Feb 18New 90-day low: US$10.32The company is down 20% from its price of US$12.86 on 19 November 2020. The American market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Household Products industry, which is down 7.0% over the same period.分析記事 • Feb 09Why We Like The Returns At Ocean Bio-Chem (NASDAQ:OBCI)Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...分析記事 • Jan 27Is Weakness In Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?Ocean Bio-Chem (NASDAQ:OBCI) has had a rough three months with its share price down 14%. However, stock prices are...分析記事 • Jan 14Do Ocean Bio-Chem's (NASDAQ:OBCI) Earnings Warrant Your Attention?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...Is New 90 Day High Low • Jan 07New 90-day low: US$12.17The company is down 20% from its price of US$15.22 on 08 October 2020. The American market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Household Products industry, which is flat over the same period.分析記事 • Jan 01This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)We'd be surprised if Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) shareholders haven't noticed that the Executive VP of Sales...Recent Insider Transactions • Dec 31Board Member recently sold US$120k worth of stockOn the 29th of December, Gregor Dornau sold around 9k shares on-market at roughly US$14.07 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$464k more than they bought in the last 12 months.分析記事 • Dec 28Shareholders of Ocean Bio-Chem (NASDAQ:OBCI) Must Be Delighted With Their 610% Total ReturnLong term investing can be life changing when you buy and hold the truly great businesses. And highest quality...分析記事 • Dec 15Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been SellingIt is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...分析記事 • Dec 03Is Ocean Bio-Chem (NASDAQ:OBCI) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...分析記事 • Nov 21A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO SalaryPeter Dornau has been the CEO of Ocean Bio-Chem, Inc. (NASDAQ:OBCI) since 1973, and this article will examine the...Valuation Update With 7 Day Price Move • Nov 21Market pulls back on stock over the past weekAfter last week's 18% share price decline to US$12.43, the stock is trading at a trailing P/E ratio of 12.5x, down from the previous P/E ratio of 15.3x. This compares to an average P/E of 24x in the Household Products industry in the US. Total returns to shareholders over the past three years are 209%.Reported Earnings • Nov 15Third quarter 2020 earnings released: EPS US$0.49The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$19.2m (up 53% from 3Q 2019). Net income: US$4.66m (up 314% from 3Q 2019). Profit margin: 24% (up from 9.0% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Nov 10Market pulls back on stock over the past weekAfter last week's 26% share price decline to US$12.50, the stock is trading at a trailing P/E ratio of 20.1x, down from the previous P/E ratio of 27.1x. This compares to an average P/E of 23x in the Household Products industry in the US. Total returns to shareholders over the past three years are 212%.Valuation Update With 7 Day Price Move • Oct 21Market bids up stock over the past weekAfter last week's 17% share price gain to US$17.48, the stock is trading at a trailing P/E ratio of 28.2x, up from the previous P/E ratio of 24.1x. This compares to an average P/E of 26x in the Household Products industry in the US. Total returns to shareholders over the past three years are 280%.Recent Insider Transactions • Sep 18COO, VP recently sold US$72k worth of stockOn the 16th of September, William Dudman sold around 5k shares on-market at roughly US$15.50 per share. In the last 3 months, there was an even bigger sale from another insider worth US$90k. William has been a seller over the last 12 months, reducing personal holdings by US$154k. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Ocean Bio-Chem は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測NasdaqCM:OBCI - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数6/30/2022635-70N/A3/31/2022648-44N/A12/31/2021648-26N/A9/30/202163905N/A6/30/2021611047N/A3/31/2021611157N/A12/31/2020561046N/A9/30/202052946N/A6/30/202046645N/A3/31/202041367N/A12/31/201942356N/A9/30/201941334N/A6/30/201942312N/A3/31/2019423-10N/A12/31/2018423-11N/A9/30/2018423-12N/A6/30/2018403-22N/A3/31/2018383-23N/A12/31/2017383-23N/A9/30/2017383-13N/A6/30/201739303N/A3/31/201738323N/A12/31/201636233N/A9/30/201636212N/A6/30/201635000N/A3/31/2016350N/A2N/A12/31/2015340N/A1N/A9/30/2015341N/A1N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: OBCIの予測収益成長が 貯蓄率 ( 1.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: OBCIの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: OBCIの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: OBCIの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: OBCIの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: OBCIの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YHousehold 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2022/08/09 20:32終値2022/08/08 00:00収益2022/06/30年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ocean Bio-Chem, Inc. これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Aug 05Second quarter 2022 earnings released: US$0.03 loss per share (vs US$0.27 profit in 2Q 2021)Second quarter 2022 results: US$0.03 loss per share (down from US$0.27 profit in 2Q 2021). Revenue: US$15.2m (down 3.1% from 2Q 2021). Net loss: US$321.4k (down 112% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
分析記事 • Jun 23Here's Why Ocean Bio-Chem (NASDAQ:OBCI) Can Manage Its Debt ResponsiblyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Valuation Update With 7 Day Price Move • Jun 22Investor sentiment improved over the past weekAfter last week's 101% share price gain to US$12.86, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 20x in the Household Products industry in the US. Total returns to shareholders of 298% over the past three years.
Reported Earnings • May 16First quarter 2022 earnings released: EPS: US$0.14 (vs US$0.20 in 1Q 2021)First quarter 2022 results: EPS: US$0.14 (down from US$0.20 in 1Q 2021). Revenue: US$12.7m (down 3.0% from 1Q 2021). Net income: US$1.30m (down 32% from 1Q 2021). Profit margin: 10% (down from 14% in 1Q 2021). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 7 highly experienced directors. 3 independent directors (5 non-independent directors). Independent Director Kim Krause was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
分析記事 • Apr 07Capital Investments At Ocean Bio-Chem (NASDAQ:OBCI) Point To A Promising FutureIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...
Reported Earnings • Apr 01Full year 2021 earnings released: EPS: US$0.89 (vs US$1.02 in FY 2020)Full year 2021 results: EPS: US$0.89 (down from US$1.02 in FY 2020). Revenue: US$64.3m (up 16% from FY 2020). Net income: US$8.40m (down 13% from FY 2020). Profit margin: 13% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.
分析記事 • Dec 16Ocean Bio-Chem (NASDAQ:OBCI) Might Become A Compounding MachineIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
分析記事 • Nov 26Ocean Bio-Chem's (NASDAQ:OBCI) Dividend Will Be US$0.03Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) will pay a dividend of US$0.03 on the 21st of December. This means the annual...
分析記事 • Nov 22Ocean Bio-Chem's (NASDAQ:OBCI) Shareholders Have More To Worry About Than Only Soft EarningsA lackluster earnings announcement from Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) last week didn't sink the stock price. We...
Valuation Update With 7 Day Price Move • Nov 22Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to US$9.50, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 24x in the Household Products industry in the US. Total returns to shareholders of 182% over the past three years.
Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS US$0.34 (vs US$0.49 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: US$21.5m (up 12% from 3Q 2020). Net income: US$3.27m (down 30% from 3Q 2020). Profit margin: 15% (down from 24% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.
分析記事 • Nov 03These 4 Measures Indicate That Ocean Bio-Chem (NASDAQ:OBCI) Is Using Debt SafelySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
分析記事 • Sep 02Ocean Bio-Chem (NASDAQ:OBCI) Will Pay A Dividend Of US$0.03Ocean Bio-Chem, Inc.'s ( NASDAQ:OBCI ) investors are due to receive a payment of US$0.03 per share on 23rd of...
Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS US$0.27 (vs US$0.36 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: US$31.4m (up 100% from 2Q 2020). Net income: US$6.69m (up 94% from 2Q 2020). Profit margin: 21% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.
分析記事 • Aug 17With EPS Growth And More, Ocean Bio-Chem (NASDAQ:OBCI) Is InterestingLike a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Valuation Update With 7 Day Price Move • Aug 16Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to US$8.99, the stock trades at a trailing P/E ratio of 7.8x. Average trailing P/E is 21x in the Household Products industry in the US. Total returns to shareholders of 138% over the past three years.
Seeking Alpha • Aug 05Ocean Bio-Chem And Its Real ValueOver a year and a half, OBCI shares have increased by 212.3%. OBCI had an impressive EBIT growth of 220% over the last year. Its operating margin is 22.90%, ranking better than 91% of the companies in Conglomerates industry. This article tells what investors could likely make in the future with OBCI and what the real value is versus the current share price.
分析記事 • Jul 27Is Ocean Bio-Chem (NASDAQ:OBCI) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$13.00, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 17x in the Household Products industry in the US. Total returns to shareholders of 261% over the past three years.
Valuation Update With 7 Day Price Move • Jun 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$12.83, the stock trades at a trailing P/E ratio of 11.2x. Average trailing P/E is 18x in the Household Products industry in the US. Total returns to shareholders of 269% over the past three years.
分析記事 • May 29Estimating The Intrinsic Value Of Ocean Bio-Chem, Inc. (NASDAQ:OBCI)Does the May share price for Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) reflect what it's really worth? Today, we will...
分析記事 • May 17Investors Should Be Encouraged By Ocean Bio-Chem's (NASDAQ:OBCI) Returns On CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Reported Earnings • May 16First quarter 2021 earnings released: EPS US$0.20 (vs US$0.066 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$13.1m (up 68% from 1Q 2020). Net income: US$1.90m (up 204% from 1Q 2020). Profit margin: 14% (up from 8.0% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year whereas the company’s share price has increased by 50% per year.
Valuation Update With 7 Day Price Move • Apr 20Investor sentiment improved over the past weekAfter last week's 19% share price gain to US$14.17, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 20x in the Household Products industry in the US. Total returns to shareholders of 308% over the past three years.
Reported Earnings • Apr 03Full year 2020 earnings released: EPS US$1.02 (vs US$0.37 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: US$55.6m (up 32% from FY 2019). Net income: US$9.62m (up 175% from FY 2019). Profit margin: 17% (up from 8.3% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 46% per year whereas the company’s share price has increased by 49% per year.
分析記事 • Mar 17Ocean Bio-Chem (NASDAQ:OBCI) Seems To Use Debt Rather SparinglyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Valuation Update With 7 Day Price Move • Mar 13Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$12.50, the stock is trading at a trailing P/E ratio of 12.6x, up from the previous P/E ratio of 10.9x. This compares to an average P/E of 21x in the Household Products industry in the US. Total returns to shareholders over the past three years are 239%.
分析記事 • Mar 05Be Sure To Check Out Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Before It Goes Ex-DividendOcean Bio-Chem, Inc. ( NASDAQ:OBCI ) is about to trade ex-dividend in the next four days. If you purchase the stock on...
分析記事 • Feb 22Why Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Is A Dividend RockstarDividend paying stocks like Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) tend to be popular with investors, and for good reason...
Valuation Update With 7 Day Price Move • Feb 18Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to US$10.32, the stock is trading at a trailing P/E ratio of 10.4x, down from the previous P/E ratio of 13x. This compares to an average P/E of 19x in the Household Products industry in the US. Total returns to shareholders over the past three years are 177%.
Is New 90 Day High Low • Feb 18New 90-day low: US$10.32The company is down 20% from its price of US$12.86 on 19 November 2020. The American market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Household Products industry, which is down 7.0% over the same period.
分析記事 • Feb 09Why We Like The Returns At Ocean Bio-Chem (NASDAQ:OBCI)Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...
分析記事 • Jan 27Is Weakness In Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?Ocean Bio-Chem (NASDAQ:OBCI) has had a rough three months with its share price down 14%. However, stock prices are...
分析記事 • Jan 14Do Ocean Bio-Chem's (NASDAQ:OBCI) Earnings Warrant Your Attention?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Is New 90 Day High Low • Jan 07New 90-day low: US$12.17The company is down 20% from its price of US$15.22 on 08 October 2020. The American market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Household Products industry, which is flat over the same period.
分析記事 • Jan 01This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)We'd be surprised if Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) shareholders haven't noticed that the Executive VP of Sales...
Recent Insider Transactions • Dec 31Board Member recently sold US$120k worth of stockOn the 29th of December, Gregor Dornau sold around 9k shares on-market at roughly US$14.07 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$464k more than they bought in the last 12 months.
分析記事 • Dec 28Shareholders of Ocean Bio-Chem (NASDAQ:OBCI) Must Be Delighted With Their 610% Total ReturnLong term investing can be life changing when you buy and hold the truly great businesses. And highest quality...
分析記事 • Dec 15Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been SellingIt is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
分析記事 • Dec 03Is Ocean Bio-Chem (NASDAQ:OBCI) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 • Nov 21A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO SalaryPeter Dornau has been the CEO of Ocean Bio-Chem, Inc. (NASDAQ:OBCI) since 1973, and this article will examine the...
Valuation Update With 7 Day Price Move • Nov 21Market pulls back on stock over the past weekAfter last week's 18% share price decline to US$12.43, the stock is trading at a trailing P/E ratio of 12.5x, down from the previous P/E ratio of 15.3x. This compares to an average P/E of 24x in the Household Products industry in the US. Total returns to shareholders over the past three years are 209%.
Reported Earnings • Nov 15Third quarter 2020 earnings released: EPS US$0.49The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$19.2m (up 53% from 3Q 2019). Net income: US$4.66m (up 314% from 3Q 2019). Profit margin: 24% (up from 9.0% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Nov 10Market pulls back on stock over the past weekAfter last week's 26% share price decline to US$12.50, the stock is trading at a trailing P/E ratio of 20.1x, down from the previous P/E ratio of 27.1x. This compares to an average P/E of 23x in the Household Products industry in the US. Total returns to shareholders over the past three years are 212%.
Valuation Update With 7 Day Price Move • Oct 21Market bids up stock over the past weekAfter last week's 17% share price gain to US$17.48, the stock is trading at a trailing P/E ratio of 28.2x, up from the previous P/E ratio of 24.1x. This compares to an average P/E of 26x in the Household Products industry in the US. Total returns to shareholders over the past three years are 280%.
Recent Insider Transactions • Sep 18COO, VP recently sold US$72k worth of stockOn the 16th of September, William Dudman sold around 5k shares on-market at roughly US$15.50 per share. In the last 3 months, there was an even bigger sale from another insider worth US$90k. William has been a seller over the last 12 months, reducing personal holdings by US$154k.